InMode

INMD

Market cap $847M

InMode Ltd. remains a global leader in minimally-invasive aesthetics, with proprietary RF and laser technologies and a strong international growth trajectory. I maintain a Strong Buy rating for INMD, citing undervaluation, robust free cash flow, a fortress balance sheet, and aggressive share repurchases. U.S. market saturation and sales execution remain challenges, but leadership changes and new product launches are driving positive cultural and operational shifts.

YOKNEAM, Israel, May 20, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode" or the "Company"), a leading global provider of innovative medical technologies, today announced the appointment of Dr. Shlomo Nass as Chairman of the Company's Board of Directors (the "Board") and Moshik Itzkovich as Chief Financial Officer, effective immediately.

YOKNEAM, Israel, May 13, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences and events:   Barclays Virtual West Coast Bus Trip Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance Format: Virtual investor bus tour When: Wednesday, May 20 Jefferies Global Healthcare Conference Presenters: Yair Malca, Outgoing Chief Financial Officer and Moshik Itzkovich, Senior VP of Finance Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst and one-on-one meetings When: Wednesday, June 3, fireside chat at 12:45 pm ET Location: New York, NY A live webcast of the presentation can be accessed here.

InMode Ltd. (INMD) Q1 2026 Earnings Call Transcript

YOKNEAM, Israel, May 6, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the first quarter of 2026.

Aesthetic firms are betting that a growing pool of patients experiencing loose skin and facial volume loss from GLP-1 obesity drugs will fuel a new wave of demand, as the sector heads into first-quarter earnings this week.

Conference call to be held on Wednesday, May 6, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, April 13, 2026 /PRNewswire/ -- InMode Ltd.

YOKNEAM, Israel, March 24, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Moshe Mizrahy, Chief Executive Officer and Yair Malca, Chief Financial Officer will present at the 25th Annual Needham Virtual Healthcare Conference on Monday, April 13, 2026.

YOKNEAM, Israel, March 13, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the Company's total shares outstanding, representing approximately 6.38 million ordinary shares.

InMode Ltd. (INMD) Presents at Barclays 28th Annual Global Healthcare Conference Transcript